Sihuan Pharmaceutical Holdings Group Ltd
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sihuan Pharmaceutical Holdings Group Ltd
Indian firm Strides announces its entry into China through a joint venture with one of the country’s leading pharmaceutical firms, as first-quarter EBITDA soars 155%.
Amicus announced its ambitions in gene therapy last year, recently purchased Celenex and 10 pipeline candidates, and now partners with Penn on gene therapies. Celltrion is collaborating with Emory in atherosclerosis therapies.
Chinese pharma and biotech grew increasingly active in deal-makings in the past months, with the largest outbound acquisition on record in April, a €1.3bn takeover deal made by Creat Group to German Biotest, while domestic big pharmas allotting investment to set up biologic divisions.
China’s FDA says of the 5,161 samples tested, 2,335 were substandard. Of 90 manufacturers that submitted results after conducting self-checks, 55 were reported to have quality issues.
- Generic Drugs
- Other Names / Subsidiaries
- KBP BioSciences Pharmaceutical Technical Co., Ltd.
- Shandong Xuanzhu Pharma Co., Ltd.